The Lokayukta has unearthed a scam in purchase of drugs in government hospitals, causing huge losses to exchequer.
Lokayukta Santosh Hegde said they have submitted a report. “Accordingly, we have made suggestions under the Karnataka Transparency in Public Procurements Act and held certain officers responsible. Now the ball is in the government court and they have to initiate action,” he said.
The report has indicted the purchasing authority for government hospitals for indulging in malpractices in drug purchases causing huge losses. The report, based on one prepared by a committee of doctors entrusted with the probe, states the authority has been indulging in malpractices, causing huge losses to the government, Hegde said.
The Lokayukta entrusted the probe to this committee after complaints that some department officers in 2010-11 had placed orders worth Rs 50 crore. It found the charges true after preliminary examination and submitted an interim report to it. Lokayukta then directed the Additional Director Karnataka State Drugs Logistics and Warehousing Society (KSDL & WS) not to procure the drugs. Subsequently they filed an application before the Lokayukta, explaining their stand.
The Lokayukta passed an order on June 5, 2010 stating that barring 25 drugs, other drugs could be purchased. The probe pointed out there was a “conspiracy” to purchase drugs not permitted and also indicted some officers of KSDL & WS of being a part of it.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app